Literature DB >> 18184644

Placental infection with human papillomavirus is associated with spontaneous preterm delivery.

L M Gomez1, Y Ma, C Ho, C M McGrath, D B Nelson, S Parry.   

Abstract

BACKGROUND: We sought to determine if human papillomavirus (HPV) infection of extravillous trophoblast cells reduces cell invasion and if placental infection is associated with adverse reproductive outcomes attributed to placental dysfunction.
METHODS: We conducted apoptosis and invasion assays using extravillous trophoblast (HTR-8/SVneo) cells that were transfected with a plasmid (pAT-HPV-16) containing the entire HPV-16 genome. In order to associate HPV infection with reproductive outcomes, we conducted a case-control study to detect HPV DNA in the extravillous trophoblast region of placentas from cases of spontaneous preterm delivery, severe pre-eclampsia requiring delivery at <37 weeks and controls who delivered at term.
RESULTS: Rates of apoptosis were 3- to 6-fold greater in transfected cells than in non-transfected cells or cells transfected with an empty plasmid. Invasion of transfected cells through extracellular matrices was 25-58% lower than that of the controls. HPV was detected more frequently in placentas from spontaneous preterm deliveries than in placentas from controls (P = 0.03). Identification of HPV in placentas from cases of pre-eclampsia was not significantly different to controls.
CONCLUSIONS: HPV infection of extravillous trophoblast induces cell death and may reduce placental invasion into the uterine wall. Thus, HPV infection may cause placental dysfunction and is associated with adverse pregnancy outcomes, including spontaneous preterm delivery.

Entities:  

Mesh:

Year:  2008        PMID: 18184644     DOI: 10.1093/humrep/dem404

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  63 in total

Review 1.  Pathogens and the placental fortress.

Authors:  Jennifer R Robbins; Anna I Bakardjiev
Journal:  Curr Opin Microbiol       Date:  2011-12-12       Impact factor: 7.934

2.  Cutting Edge: Fetal/Placental Type I IFN Can Affect Maternal Survival and Fetal Viral Load during Viral Infection.

Authors:  Karen Racicot; Paulomi Aldo; Ayman El-Guindy; Ja-Young Kwon; Roberto Romero; Gil Mor
Journal:  J Immunol       Date:  2017-03-06       Impact factor: 5.422

3.  Low-Dose Aspirin May Prevent Trophoblast Dysfunction in Women With Chlamydia Pneumoniae Infection.

Authors:  Luis M Gomez; Lauren Anton; Shindu K Srinivas; Michal A Elovitz; Samuel Parry
Journal:  Reprod Sci       Date:  2018-12-20       Impact factor: 3.060

4.  Introduction to Environmental Harmful Factors.

Authors:  Jiarong Guo; Peng Tian; Zhongyan Xu; Huidong Zhang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Risks associated with viral infections during pregnancy.

Authors:  Karen Racicot; Gil Mor
Journal:  J Clin Invest       Date:  2017-05-01       Impact factor: 14.808

6.  Human papillomavirus vaccine and pregnancy.

Authors:  Andrea Narducci; Adrienne Einarson; Pina Bozzo
Journal:  Can Fam Physician       Date:  2012-03       Impact factor: 3.275

7.  A clinicopathological study of episomal papillomavirus infection of the human placenta and pregnancy complications.

Authors:  Tania L Slatter; Natalie Gly Hung; William M Clow; Janice A Royds; Celia J Devenish; Noelyn A Hung
Journal:  Mod Pathol       Date:  2015-08-21       Impact factor: 7.842

8.  Transplacental Transmission of Human Papillomavirus.

Authors:  Anca Florina Zgura; Elvira Bratila; Simona Vladareanu
Journal:  Maedica (Buchar)       Date:  2015-06

9.  Activation of TLR3 in the trophoblast is associated with preterm delivery.

Authors:  Kaori Koga; Ingrid Cardenas; Paulomi Aldo; Vikki M Abrahams; Bing Peng; Sara Fill; Roberto Romero; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2009-03       Impact factor: 3.886

Review 10.  Understanding the complexity of the immune system during pregnancy.

Authors:  Karen Racicot; Ja-Young Kwon; Paulomi Aldo; Michelle Silasi; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2014-07-04       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.